Please try another search
For the six months ended 28 February 2022, Opsens Inc. revenues decreased 6% to C$16.2M. Net loss totaled C$4.5M vs. income of C$635K. Revenues reflect Medical segment decrease of 5% to C$14.5M, Industrial segment decrease of 13% to C$1.7M, Japan segment decrease of 47% to C$2.2M. Net loss reflects Sales and marketing increase of 46% to C$4.6M (expense), Research and development increase of 47% to C$3.8M (expense).
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Total Revenue | 8.1 | 8.1 | 8.07 | 9.23 |
Gross Profit | 4.17 | 4.12 | 4.02 | 5.42 |
Operating Income | -2.4 | -2.06 | -1.23 | -0.55 |
Net Income | -2.4 | -2.09 | -1.21 | -0.57 |
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Total Assets | 50.51 | 51.68 | 58.51 | 60.18 |
Total Liabilities | 10.54 | 10.13 | 16.18 | 17.2 |
Total Equity | 39.97 | 41.55 | 42.33 | 42.98 |
Period Ending: | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -2.25 | -1.26 | 2.84 | 2.45 |
Cash From Investing Activities | -0.34 | -0.22 | -0.94 | -0.76 |
Cash From Financing Activities | -5.02 | -5.13 | 25.88 | 26.37 |
Net Change in Cash | -7.62 | -6.6 | 27.68 | 27.89 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review